A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein
暂无分享,去创建一个
[1] D. Kasper,et al. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Brisson,et al. Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide (*) , 1996, The Journal of Biological Chemistry.
[3] A. Schuchat,et al. Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.
[4] D. Kasper,et al. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1995, The Journal of infectious diseases.
[5] L. Harrison,et al. Emergence of serotype V group B streptococcal infection among infants and adults. , 1995, Journal of Infectious Diseases.
[6] M. Wagner,et al. JM9 strains, a new type of group B streptococci from Japan. , 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[7] A. Schuchat,et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.
[8] G. Lindahl,et al. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections , 1993, The Journal of experimental medicine.
[9] D. Kasper,et al. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein , 1992, Infection and immunity.
[10] A. Schuchat,et al. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[11] F. Ausubel,et al. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Kasper,et al. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine , 1992, Infection and immunity.
[13] D. Kasper,et al. Neonatal mouse model of group B streptococcal infection. , 1992, The Journal of infectious diseases.
[14] D. Kasper,et al. Phenotypic diversity in the alpha C protein of group B streptococci , 1991, Infection and immunity.
[15] F. Ausubel,et al. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity , 1991, Infection and immunity.
[16] D. Kasper,et al. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci , 1991, Infection and immunity.
[17] A. Hightower,et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.
[18] D. Kasper,et al. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. , 1990, The Journal of clinical investigation.
[19] Y. Nishiyama,et al. Antigenicity of group B Streptococcus strain "M9" and its prevalence in Japan. , 1990, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
[20] P. Ferrieri,et al. Molecular species of R-protein antigens produced by clinical isolates of group B streptococci , 1989, Journal of clinical microbiology.
[21] D. Kasper,et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. , 1989, The New England journal of medicine.
[22] P. Christensen,et al. Correlation between low levels of maternal IgG antibodies to R protein and neonatal septicemia with group B streptococci carrying R protein. , 1983, International archives of allergy and applied immunology.
[23] H. Wilkinson. Comparison of streptococcal R antigens. , 1972, Applied microbiology.
[24] G. Perlmann,et al. PREPARATION AND PROPERTIES OF A PROTEIN (R ANTIGEN) OCCURRING IN STREPTOCOCCI OF GROUP A, TYPE 28 AND IN CERTAIN STREPTOCOCCI OF OTHER SEROLOGICAL GROUPS , 1952, The Journal of experimental medicine.